TG Therapeutics, Inc. (BIT:1TGTX)

TG Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 20, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,571	4,173	2,186	1,482	2,188	5,479
Market Cap Growth	159.56%	90.90%	47.46%	-32.24%	-60.07%	464.68%
Enterprise Value	4,552	4,088	2,078	1,395	1,899	5,306
PE Ratio	126.18	184.75	190.66	-	-	-
PS Ratio	12.79	13.13	10.34	568.84	371.96	44096.70
PB Ratio	20.82	19.43	15.05	27.04	10.49	12.91
P/TBV Ratio	20.82	19.43	15.05	27.41	10.53	12.93
EV/Sales Ratio	13.80	12.87	9.83	535.24	322.82	42698.06
EV/EBITDA Ratio	85.92	100.79	110.20	-	-	-
EV/EBIT Ratio	89.16	100.95	111.33	-	-	-
Debt / Equity Ratio	1.07	1.14	0.69	1.42	0.34	0.08
Debt / EBITDA Ratio	4.10	5.74	4.82	-	-	-
Asset Turnover	0.75	0.73	0.89	0.01	0.01	0
Inventory Turnover	0.41	0.51	-	-	-	-
Quick Ratio	2.91	4.85	5.00	3.04	4.84	6.92
Current Ratio	4.02	6.25	5.92	3.16	5.06	6.99
Return on Equity (ROE)	19.70%	12.21%	11.57%	-151.36%	-92.03%	-100.14%
Return on Assets (ROA)	7.26%	5.78%	4.93%	-47.61%	-42.87%	-43.36%
Return on Capital (ROIC)	9.79%	7.00%	6.24%	-59.52%	-49.04%	-53.28%
Return on Capital Employed (ROCE)	12.00%	8.60%	7.50%	-	-	-
Earnings Yield	0.79%	0.54%	0.52%	-14.13%	-13.99%	-4.17%
FCF Yield	-1.24%	-0.94%	-1.30%	-11.12%	-11.90%	-3.21%
Buyback Yield / Dilution	-9.66%	-7.96%	-9.67%	-2.41%	-14.64%	-30.51%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.